Korea National Institute of Health to Share COVID19 Biospecimens and Related Data for Research

The Korea National Institute of Health said that it will publicly share its multi-omics data, clinical data, and human biobank samples from COVID-19 patients.

Multiomics refers to integrated data produced to genetically, functionally, and environmentally understand the collection of particles and cells from human biobank samples.

The institute said that it has acquired clinical data and biobank samples from 300 COVID-19 patients and 120 non-COVID-19 patients through ethical and legal agreement procedures.

Click here to read more.

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.